StreetInsider.com News Articles

Form 4 INTERPACE BIOSCIENCES, For: Jan 20 Filed by: 1315 Capital II, L.P.

Tue, 17 Feb 2026 16:06:00 -0500

si-local-file:///var/storage/secattach/20260217/26012450.html

Form 4 INTERPACE BIOSCIENCES, For: Jan 20 Filed by: 1315 Capital II, L.P.

Tue, 17 Feb 2026 16:06:00 -0500

si-local-file:///var/storage/secattach/20260217/26012450.html

Form 4 INTERPACE BIOSCIENCES, For: Jan 20 Filed by: Ampersand 2018 Limited Partnership

Wed, 04 Feb 2026 18:46:00 -0500

si-local-file:///var/storage/secattach/20260204/25948610.html

Form 4 INTERPACE BIOSCIENCES, For: Jan 20 Filed by: Ampersand 2018 Limited Partnership

Wed, 04 Feb 2026 18:46:00 -0500

si-local-file:///var/storage/secattach/20260204/25948610.html

Form 8-K INTERPACE BIOSCIENCES, For: Jan 20

Tue, 20 Jan 2026 09:06:00 -0500

si-local-file:///var/storage/secattach/20260120/25865820.html

Form 8-K INTERPACE BIOSCIENCES, For: Jan 20

Tue, 20 Jan 2026 09:06:00 -0500

si-local-file:///var/storage/secattach/20260120/25865820.html

Form 8-K INTERPACE BIOSCIENCES, For: Dec 03

Wed, 03 Dec 2025 16:05:00 -0500

si-local-file:///var/storage/secattach/20251203/25695409.html

Form 8-K INTERPACE BIOSCIENCES, For: Dec 03

Wed, 03 Dec 2025 16:05:00 -0500

si-local-file:///var/storage/secattach/20251203/25695409.html

Interpace Biosciences (IDXG) Reports Q3 EPS of $0.04

Thu, 13 Nov 2025 06:23:46 -0500

Interpace Biosciences (OTC: IDXG) reported Q3 EPS of $0.04. Revenue for the quarter came in at $8.76 million.

For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.

Form 8-K INTERPACE BIOSCIENCES, For: Nov 12

Wed, 12 Nov 2025 16:46:00 -0500

si-local-file:///var/storage/secattach/20251112/25599177.html

Form 8-K INTERPACE BIOSCIENCES, For: Nov 12

Wed, 12 Nov 2025 16:46:00 -0500

si-local-file:///var/storage/secattach/20251112/25599177.html

Form 10-Q INTERPACE BIOSCIENCES, For: Sep 30

Wed, 12 Nov 2025 16:18:00 -0500

si-local-file:///var/storage/secattach/20251112/25598487.html

Form 10-Q INTERPACE BIOSCIENCES, For: Sep 30

Wed, 12 Nov 2025 16:18:00 -0500

si-local-file:///var/storage/secattach/20251112/25598487.html

Form 8-K INTERPACE BIOSCIENCES, For: Aug 07

Fri, 08 Aug 2025 16:29:00 -0500

si-local-file:///var/storage/secattach/20250808/25175170.html

Form 8-K INTERPACE BIOSCIENCES, For: Aug 07

Fri, 08 Aug 2025 16:29:00 -0500

si-local-file:///var/storage/secattach/20250808/25175170.html

Form 10-Q INTERPACE BIOSCIENCES, For: Jun 30

Thu, 07 Aug 2025 16:31:00 -0500

si-local-file:///var/storage/secattach/20250807/25168489.html

Form 10-Q INTERPACE BIOSCIENCES, For: Jun 30

Thu, 07 Aug 2025 16:31:00 -0500

si-local-file:///var/storage/secattach/20250807/25168489.html

Interpace Biosciences Announces Second Quarter 2025 Financial and Business Results

Thu, 07 Aug 2025 16:05:00 -0500

●

Q2 Revenue of $9.2 million

●

Q2 Cash Collections of $10.8 million

●

Q2 Thyroid test volume up 16% year-over-year to record levels

●

Q2 Thyroid revenue of $8.7M;

Interpace Biosciences Announces Second Quarter 2025 Financial and Business Results

Thu, 07 Aug 2025 16:05:00 -0500

● Q2 Revenue of $9.2 million
● Q2 Cash Collections of $10.8 million
● Q2 Thyroid test volume up 16% year-over-year to record levels
● Q2 Thyroid revenue of $8.7M;

Interpace Biosciences Announces Second Quarter 2025 Financial and Business Results

Thu, 07 Aug 2025 16:05:00 -0500

● Q2 Revenue of $9.2 million
● Q2 Cash Collections of $10.8 million
● Q2 Thyroid test volume up 16% year-over-year to record levels
● Q2 Thyroid revenue of $8.7M;

Interpace Biosciences Announces Second Quarter 2025 Financial and Business Results

Thu, 07 Aug 2025 16:05:00 -0500

● Q2 Revenue of $9.2 million
● Q2 Cash Collections of $10.8 million
● Q2 Thyroid test volume up 16% year-over-year to record levels
● Q2 Thyroid revenue of $8.7M;

Interpace Biosciences (IDXG) Reports Q1 EPS of $0.06

Fri, 09 May 2025 16:46:22 -0500

Interpace Biosciences (OTC: IDXG) reported Q1 EPS of $0.06, versus $0.00 reported last year. Revenue for the quarter came in at $11.5 million versus the consensus estimate of $0 .
GUIDANCE:
Interpace Biosciences sees FY2025 revenue of $38 million.
For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.

Interpace Biosciences (IDXG) Reports Q1 EPS of $0.06

Fri, 09 May 2025 16:46:22 -0500

Interpace Biosciences (OTC: IDXG) reported Q1 EPS of $0.06, versus $0.00 reported last year. Revenue for the quarter came in at $11.5 million versus the consensus estimate of $0 .
GUIDANCE:
Interpace Biosciences sees FY2025 revenue of $38 million.
For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.

Form 10-Q INTERPACE BIOSCIENCES, For: Mar 31

Thu, 08 May 2025 16:29:00 -0500
si-local-file:///var/storage/secattach/20250508/24766883.html

Form 10-Q INTERPACE BIOSCIENCES, For: Mar 31

Thu, 08 May 2025 16:29:00 -0500
si-local-file:///var/storage/secattach/20250508/24766883.html